subscribeSubscribe
J&J nixes Tremfya trial in giant cell arteritis

J&J nixes Tremfya trial in giant cell arteritis
Fraiser Kansteiner FIERCE PHARMA
26 Jun 2024
Share Share
TREMFYA Studies Show Potential For SC And IV Induction As IL-23 Inhibitor

TREMFYA Studies Show Potential For SC And IV Induction As IL-23 Inhibitor
PR NEWSWIRE
20 Jun 2024
Share Share
Innovent looks to Chinese regulators after ph. 3 psoriasis win

Innovent looks to Chinese regulators after ph. 3 psoriasis win
James Waldron FIERCE BIOTECH
28 May 2024
Share Share
J&J’s Tremfya trumps placebo, Stelara in Phase III Crohn`s trial

J&J’s Tremfya trumps placebo, Stelara in Phase III Crohn`s trial
PRESS RELEASE
22 May 2024
Share Share
TREMFYA Superiority Vs STELARA Shown In Crohn`s Phase 3

TREMFYA Superiority Vs STELARA Shown In Crohn`s Phase 3
PR NEWSWIRE
21 May 2024
Share Share
TREMFYA UC Maintenance Study Meets Primary & Major Secondary Endpoints

TREMFYA UC Maintenance Study Meets Primary & Major Secondary Endpoints
PR NEWSWIRE
20 May 2024
Share Share
J&J readies Tremfya for IBD showdown with AbbVie, Lilly

J&J readies Tremfya for IBD showdown with AbbVie, Lilly
Angus Liu FIERCE PHARMA
20 May 2024
Share Share
J&J Seeks EMA Approval For Tremfya In UC, Crohn`s Disease

J&J Seeks EMA Approval For Tremfya In UC, Crohn`s Disease
PR NEWSWIRE
01 May 2024
Share Share
J&J submits supplemental BLA to U.S. FDA seeking approval of TREMFYA

J&J submits supplemental BLA to U.S. FDA seeking approval of TREMFYA
PR NEWSWIRE
11 Mar 2024
Share Share
TREMFYA® (guselkumab) Demonstrates Significant and Rapid Scalp Psoriasis Clearance in People of Color in New Large Phase 3b Study

TREMFYA® (guselkumab) Demonstrates Significant and Rapid Scalp Psoriasis Clearance in People of Color in New Large Phase 3b Study
PR NEWSWIRE
22 Jan 2024
Share Share